Adapting an Expanded Access program to enable investigational treatments for COVID-19
Retrospective case studies of initiatives supported by the National Institutes of Health’s Clinical and Translational Science Award (CTSA) hubs can be used to identify facilitators and barriers of translational science. This case study investigates how a CTSA Expanded Access program adapted to chang...
Main Authors: | Elias Samuels, Ellen Champagne, Misty Gravelin, Jamie Racklyeft, Kevin Weatherwax |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-01-01
|
Series: | Journal of Clinical and Translational Science |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866122004034/type/journal_article |
Similar Items
-
National landscape assessment of academic medical center support for expanded access to investigational products
by: Misty Gravelin, et al.
Published: (2023-01-01) -
Training the translational workforce: Expanding beyond translational research to include translational science
by: Joel Tsevat, et al.
Published: (2020-08-01) -
Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic
by: Misty Gravelin, et al.
Published: (2021-01-01) -
Effect of a Clinical and Translational Science Award institute on grant funding in a major research university
by: Felichism W. Kabo, et al.
Published: (2017-04-01) -
Advancing well-being in clinical and translational science
by: Miriam A. Bredella, et al.
Published: (2024-01-01)